Health ❯ Healthcare

Diagnostics

Blood Tests Biomarkers Molecular Diagnostics Imaging Techniques Laboratory Tests Genetic Testing Molecular Testing Liquid Biopsy Companion Diagnostics Medical Testing

5 ARTICLES

16h ago

Investigational Blood Test Accurately Flags Early Pancreatic Cancer in Large International Study

A Nature Medicine study shows PANXEON’s AI‑driven combo of CA19‑9 and microRNA signals can detect many stage I–II tumors but requires prospective trials before clinical use.

Stories older than 24h

6 ARTICLES

last wk.

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

3 ARTICLES

2w ago

Juventus Confirm Thuram Knee Surgery as Cabal Is Ruled Out With Muscle Lesion

8 ARTICLES

3w ago

FDA Approves Zanidatamab Regimens for First‑Line HER2‑Positive Gastroesophageal Cancer

7 ARTICLES

3w ago

FDA Clears Roche and Eli Lilly Blood Test to Help Assess Alzheimer’s-Linked Brain Changes

3 ARTICLES

3w ago

Highly Sensitive Blood Test Accurately Identifies Active Tuberculosis in Early Study

4 ARTICLES

last mo.

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

25 ARTICLES

2mo ago

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

4 ARTICLES

2mo ago

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

3 ARTICLES

2mo ago

Zydus and Apollo Begin Offering Guardant’s Shield Blood Screen for 10 Cancers in India

3 ARTICLES

2mo ago

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

16 ARTICLES

3mo ago

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

8 ARTICLES

3mo ago

Cambridge Nanosensor Shows Urine Signal for Early Lung Cancer

6 ARTICLES

3mo ago

Jardine Matheson to Buy I‑MED for A$3.4 Billion

3 ARTICLES

3mo ago

Possible Ebola Patient Admitted to RadboudUMC as WHO Flags Outbreak in Congo

Diagnostics

Investigational Blood Test Accurately Flags Early Pancreatic Cancer in Large International Study

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

Juventus Confirm Thuram Knee Surgery as Cabal Is Ruled Out With Muscle Lesion

FDA Approves Zanidatamab Regimens for First‑Line HER2‑Positive Gastroesophageal Cancer

FDA Clears Roche and Eli Lilly Blood Test to Help Assess Alzheimer’s-Linked Brain Changes

Druckenmiller Makes Natera His Largest Holding After Strong Q2 Results

FDA Clears PrecivityAD2 Blood Test for Symptomatic Adults Aged 40 and Up

IIT Indore Identifies Saliva and Swab Markers That Signal Early Oral Cancer

Natera Shares Surge After Blowout Signatera Quarter and Japan Approval

Australia Approves pTau217 Blood Test, Launches Asia‑Pacific Alzheimer’s Centre

Never miss stories about

Diagnostics

Highly Sensitive Blood Test Accurately Identifies Active Tuberculosis in Early Study

New Blood Biomarkers Differentiate Alzheimer’s Risk by Disease Stage

Blood p‑tau217 Test Predicts Elevated 5‑ and 10‑Year Alzheimer’s Risk

Blood Test p‑tau217 Predicts Alzheimer Risk but Not Ready for Routine Screening

Zydus and Apollo Begin Offering Guardant’s Shield Blood Screen for 10 Cancers in India

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Cambridge Nanosensor Shows Urine Signal for Early Lung Cancer

Jardine Matheson to Buy I‑MED for A$3.4 Billion

Possible Ebola Patient Admitted to RadboudUMC as WHO Flags Outbreak in Congo

Never miss stories about

Diagnostics